Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award Director acquired 13,700 shares (grant or award)
  2. 4 Grant or award Director acquired 13,700 shares (grant or award)
  3. 4 Grant or award Director acquired 13,700 shares (grant or award)
  4. 4 Grant or award Director acquired 13,700 shares (grant or award)
  5. 4 Grant or award Director acquired 13,700 shares (grant or award)
  6. 4 Grant or award Director acquired 13,700 shares (grant or award)
  7. 4 Grant or award Director acquired 13,700 shares (grant or award)
  8. 4 Grant or award Director acquired 13,700 shares (grant or award)
  9. 4 Grant or award Director acquired 13,700 shares (grant or award)
  10. 4 Exercise or conversion CEO and President acquired 287,000 shares (option exercise)
  11. 4 Grant or award CCO acquired 25,000 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Returned to the company SVP, Chief Medical Officer returned 4,409 shares (to the company)
  14. 4 Returned to the company SVP, Chief Business Officer returned 11,909 shares (to the company)
  15. 4 Returned to the company SVP, CLO & Secretary returned 11,929 shares (to the company)
  16. 4 Returned to the company SVP, Chief Development Officer returned 6,075 shares (to the company)
  17. 4 Returned to the company SVP, CFO & Treasurer returned 13,148 shares (to the company)
  18. 4 Grant or award SVP, Chief Development Officer acquired 30,000 shares (grant or award)
  19. 4 Grant or award SVP, Chief Medical Officer acquired 80,000 shares (grant or award)
  20. 4 Grant or award SVP, Chief Business Officer acquired 65,000 shares (grant or award)

Page 10 of 19 · 378 filings